Gambia vs Italy: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Gambia
82.0%
in 2025
Italy
82.0%
in 2025
Gambia rank
106th
Italy rank
106th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Gambia
- Italy
How they compare
Gambia currently reports 82.0% against 82.0% in Italy, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Italy ahead.
Gambia ranks 106th and Italy ranks 106th of 194 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Italy in 2.
Head to head by decade
| Decade | Gambia | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 63.0% | 63.0% | Italy |
| 2010s | 94.6% | 85.5% | 9.1% | Gambia |
| 2020s | 79.7% | 89.7% | 10.0% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Gambia or Italy?
- Gambia, at 82.0% against 82.0% in Italy as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Gambia and Italy?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Italy?
- 18 years are reported by both, from 2008 to 2025.
- How do Gambia and Italy rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Gambia ranks 106th and Italy ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.